Highlights
- Manipal Health Enterprises IPO opens on July 29, 2026
- Manipal Health Enterprises IPO Price Band: Rs 560-590 per share
- Manipal Health Enterprises IPO Allotment Date: August 3, 2026
- Manipal Health Enterprises IPO Listing Date: August 5, 2026
Manipal Health Enterprises IPO GMP: The Manipal Health Enterprises IPO is set to open for subscription on Wednesday, July 29, 2026, marking one of the most anticipated public issues of the year. Market participants are also viewing the offering as the start of a strong IPO pipeline expected to dominate the primary market during the remainder of 2026.
Ahead of the issue, investors are closely tracking the Manipal Health Enterprises IPO GMP (Grey Market Premium), subscription timeline, allotment date, listing schedule, and the company’s plans for utilising the funds raised through the public offering.
Manipal Health Enterprises IPO GMP Today
Ahead of the IPO opening, the Manipal Health Enterprises IPO Grey Market Premium (GMP) remains relatively muted. The latest GMP stands at Rs 25 per share, indicating an estimated listing price of around Rs 615 per share, provided the premium remains unchanged until listing.
Based on the current grey market premium, the IPO could deliver an estimated listing gain of around 4.2 per cent over the upper price band of Rs 590. This translates into a potential gain of Rs 625 per lot of 25 shares.
Although the GMP offers an indication of investor sentiment in the unofficial market, it should not be considered a guaranteed predictor of the stock’s listing performance.
Manipal Health Enterprises IPO Key Dates
Manipal Health Enterprises IPO Subscription Date
The Manipal Health Enterprises IPO will open for subscription on July 29, 2026, and close on July 31, 2026.
Manipal Health Enterprises IPO Allotment Date
The basis of allotment is expected to be finalised on August 3, 2026. Investors can check their allotment status through the official websites of the NSE, BSE, and KFin Technologies, the registrar to the issue.
Manipal Health Enterprises IPO: Use of Proceeds
According to the company’s red herring prospectus (RHP), the net proceeds from the fresh issue will be utilised for the following purposes:
- Repayment or prepayment, in full or in part, of certain outstanding borrowings and accrued interest of its material subsidiary, Manipal Hospitals Private Limited.
- Acquisition of a minority stake in the step-down subsidiary, Sahyadri Hospitals Private Limited.
- General corporate purposes.
About Manipal Health Enterprises
The Manipal Health Enterprises IPO is a book-built issue worth Rs 9,275.22 crore. The public issue comprises:
- Fresh issue: 13.56 crore equity shares aggregating to Rs 8,000 crore.
- Offer for Sale (OFS): 2.16 crore equity shares aggregating to Rs 1,275.22 crore.
Manipal Health Enterprises Limited is one of India’s leading healthcare service providers, operating a wide network of multi-speciality hospitals, clinics, and diagnostic centres across the country. As of March 31, 2026, the company employed 24,240 full-time employees across its hospitals and corporate functions.
(Disclaimer: The above article is meant for informational purposes only and should not be considered as any investment advice. ET NOW DIGITAL suggests its readers/audience to consult their financial advisors before making any money-related decisions.)
